Keywords: L-DOPA; Renal assist device; Living membrane; Human kidney proximal tubule cells; Membrane biofunctionalization; l-DOPA;
مقالات ISI L-DOPA (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: L-DOPA; BH4; tetrahydrobiopterin; DSF; differential scanning fluorimetry; L-Dopa; (S)-3,4-dihydroxyphenylalanine; PAH; phenylalanine hydroxylase; PKU; phenylketonuria; TH; tyrosine hydroxylase; THD; TH deficiency; TPH2; tryptophan hydroxylase isoform 2; PD; Parki
Keywords: L-DOPA; ACSF; artificial cerebrospinal fluid; DA; dopamine; eCB; endocannabinoid; FAAH; fatty acid amide hydrolase; HEPES; 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; HFS; high-frequency stimulation; HRP; horseradish peroxidase; l-DOPA; l-3,4-dihydroxyphe
Keywords: L-DOPA; 5-HIAA; 5-hydroxyindolacetic acid; 5-HT; serotonin; 6-OHDA; 6-hydroxydopamine; AIMs; Abnormal involuntary movements; ARC; activity-regulated cytoskeletal-associated protein; DA; dopamine; DOPAC; 3,4-dihydroxyphenylacetic acid; EDTA; ethylenediaminetetraac
Keywords: L-DOPA; 5-HIAA; 5-hydroxyindoleacetic acid; 5-HT; 5-8 hydroxytryptamine; BW; blood withdrawal; CNS; central nervous system; CSF; cerebrospinal fluid; DA; dopamine; DAergic; dopaminergic; DOPAC; 3, 4-dihydroxyphenylacetic acid; Hgb; hemoglobin; HPLC; High-performa
Keywords: L-DOPA; ANDA; Abbreviated New Drug Application; BBB; blood-brain barrier; FDA; Food and Drug Administration; L-DOPA; L-3,4-dihydroxyphenylalanine; MEMS; microelectromechanical systems; NDA; New Drug Application; PTH; parathyroid hormone; SC; subcutaneous; SNHL;
Keywords: L-DOPA; DMSP; dimethylsulfoniopropionate; DMS; dimethylsulfide; LOC; lab-on-a-chip; AF; antifouling; FR; fouling-release; TBT; tributyl tin; μF; microfluidic; CNTs; carbon nanotubes; TPE; thermoset polyester; PDMS; polydimethylsiloxane; PEGDMA; poly(ethylene gly
Keywords: L-DOPA; Droxidopa; Parkinson's disease; Motor fuction; Add-on; Norepinnehrine; CGI; Clinical Global Impression rating score; FAS; full analysis set; ITT; intent-to-treat; l-DOPA; Levodopa; l-DOPS; l-threo-3,4-dihydroxyphenylserine; NE; norepinnehrine; PD; Parki
Keywords: L-DOPA; CD; circular dichroism; l-DOPA; (3,4-dihydroxyphenylalanine); DMSO; dimethyl sulfoxide; DMEM; Dulbecco's Modified Eagle's Medium; FBS; fetal bovine serum; MTT; 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide; Brazilein; Caesalpinia sappan; Ty
Keywords: L-DOPA; AAV; adeno-associated viral vectors; CPA; conditioned place aversion; CPP; conditioned place preference; DA; dopamine; DDS; dopamine dysregulation syndrome; DRT; dopamine replacement therapy; ICB; impulsive-compulsive behavior; ICSS; intracranial self-s
Keywords: L-DOPA; ADL; activities of daily living; COMT; catechol-O-methyltransferase; DOI; 2,5-dimethoxy-4-iodoamphetamine; GIRK; G-protein-gated inwardly rectifying potassium; GP; globus pallidus; GPCR; G protein-coupled receptor; GPe; external segment of GP; GPi; intern
Keywords: L-DOPA; Fear extinction; Exposure therapy; Augmented relearning; Reconsolidation; Drug development; Cognitive enhancer; 5-HT; 5-hydroxytryptamine = serotonin; AC; adenylate cyclase; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMY; amygdala; BA;
Keywords: L-DOPA; ANOVA; analysis of variance; CB1; cannabinoid receptor 1; D2; dopamine receptor 2; L-DOPA; l-3,4-dihydroxyphenylalanine; OD; orofacial dyskinesia; MAO; monoaminoxidase; PBS; phosphate buffered saline; SR141716A; 5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-
Keywords: L-DOPA; aNDF; amylase neutral-detergent fiber; CP; crude protein; DM; dry matter; EE; ether extract; L-Dopa; L-3,4-dihydroxyphenylalanine; NH3N; ammonia-nitrogen; WSC; water-soluble carbohydrates; VFA; volatile fatty acids; mm; millimeter; Mucuna pruriens; Detoxi
Keywords: L-DOPA; Computer-aided design; Structure-based design; Rosetta; Antibody; Non-canonical amino acid; Crosslinking; Binding affinity; l-DOPA
Keywords: L-DOPA; 6-OHDA; 6-hydroxyldopamine; D1R; dopamine D1 receptor; D2R; dopamine D2 receptor; DCX; doublecortin; DG; dentate gyrus; HD; Huntington's disease; L-DOPA; 3,4-dihydroxy-l-phenylalanine; micro-PET; micro-positron emission tomography; MFB; medial forebrain b
Keywords: L-DOPA; BH4; 5,6,7,8-tetrahydrobiopterin; DA; Dopamine; l-DOPA; l-3,4-dihydroxyphenylalanine; GCH; GTP cylohydrolase I; HIV; human immunodeficiency virus infection; HUVEC; human umbilical vein endothelial cells; IDO; indoleamine 2,3-dioxygenase; IFN-α -à -γ; i
Keywords: L-DOPA; Angiotensin; Candesartan; l-DOPA; Neuroprotection; Parkinson; Serotonin5-HIAA, metabolite 5-hydroxyindolacetic acid; 5-HT, serotonin; 6-OHDA, 6-hydroxydopamine; AII, angiotensin II; AT1, angiotensin type-1 receptor; AT2, angiotensin type-2 receptor; AUC,
Keywords: L-DOPA; ACh; acetylcholine; AAV; adeno-associated virus; AgRP; agouti-related protein; ArchT; archaerhodopsin; BAC; bacterial artificial chromosomes; ChRs; channelrhodopsins; DBS; deep brain stimulation; DREADDs; designer receptors exclusively activated by design
Keywords: L-DOPA; 2D/3D; two/three dimensional; AA; amino acid; AFM; atomic force microscope/microscopy; ATRP; atom transfer radical polymerization; BCA; bicinchoninic acid; bFGF; basic fibroblast growth factor; BSA; bovine serum albumin; CAM; cell adhesion molecule; CDI;
Keywords: L-DOPA; Discontinuities; Parkinson's disease; Slow finger movement; 3D ultrasound motion analysis; l-Dopa; Bradykinesia;
Keywords: L-DOPA; ANOVA; analysis of variance; AA; ascorbic acid; CSF; cerebirospinal fluid; DHA; dehydroascorbate; DβH; dopamine β-hydroxylase; l-DOPA; l-3,4-dihydroxyphenylalanine; DA; dopamine; Hepes; N-2-hydroxyethylpiperazine-Nâ²-2-ethanesulfonic acid; KRH; Krebs-R
Keywords: L-DOPA; Amitraz; Neurotoxicology; Formamidine pesticide; Male rats; Monoaminergic neurotransmitters.; TH; tyrosine hydroxylase; TRH; tryptophan hydroxylase; l-TYR; l-tryptophan; l-DOPA; l-3,4-dihydroxyphenylalanine; 5-HIA; 5-hydroxyindolaldehyde; 5-HTP; 5-hydroxy
Keywords: L-DOPA; O2â; superoxide; OHâ¢; hydroxyl radical; ATP; adenosine-5â²-triphosphate; ROS; reactive oxygen species; ETC; electron transport chain; PD; Parkinson disease; SN; substantia nigra pars compacta; DA; dopamine; LB; Lewy body; L-DOPA; levodopa, l-3,4-dihy
Keywords: L-DOPA; Aβ; amyloid β; AADC; L-amino acid decarboxylase; ACC; Anterior cingulate cortex; AD; Alzheimer's disease; aMCI; Amnestic mild cognitive impairment; APP; Amyloid precursor protein; AR; Adrenergic receptor; ATMX; atomoxetine; BDNF; Brain-derived neurotrop
Keywords: L-DOPA; Photoelectrochemical sensor; Visible LED light; FePc/TiO2; L-Dopa
L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles
Keywords: L-DOPA; Brain targeting; Blood-brain barrier; Gold nanoparticles; L-DOPA; L/D-DOPA; L/D-3,4-dihydroxyphenyalanine; DA; dopamine; 4-EC; 4-ethyl-catecholamine; BBB; blood-brain barrier; AuNF; gold nanoflower; LAT-1; large neutral amino acid transporter-1; hCMEC
5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
Keywords: L-DOPA; L-DOPA; 5alpha-reductase; Dutasteride; Parkinson's disease; Dyskinesia; 6-OHDA; Neurosteroids; Dopamine;
Solid-state fermentation of black rice bran with Aspergillus awamori and Aspergillus oryzae: Effects on phenolic acid composition and antioxidant activity of bran extracts
Keywords: L-DOPA; BRB; black rice bran; TPC; total phenolic content; DPPH; 2,2-diphenyl-1-picrylhydrazyl; l-DOPA; 3,4-dihydroxyphenylalanine; AF-BRB; A. awamori-fermented black rice bran; OF-BRB; A. oryzae-fermented black rice bran; SSF; solid-state fermentation; Black ric
Biochemical characterization of a novel tyrosine phenol-lyase from Fusobacterium nucleatum for highly efficient biosynthesis of l-DOPA
Keywords: L-DOPA; Tyrosine phenol-lyase; Fusobacterium nucleatum; Substrate specificity; Kinetic analysis; L-DOPA;
Motor fluctuations and levodopa-induced dyskinesias in dopa-responsive dystonia
Keywords: L-DOPA; Levodopa; l-dopa; Dopamine-induced dyskinesia; Dyskinesia; DRD; Dopa-responsive dystonia; Dopamine; Dopamine agonist; Carbidopa-levodopa; Ropinirole; Wearing off phenomenon; DYT5; Motor fluctuation; GCH-1;
Tamoxifen activates hypothalamic l-dopa synthesis to stimulate ovarian estrogen production in chicken
Keywords: L-DOPA; Estrogen receptor; Tamoxifen; Ovary; l-dopa; Hypothalamus;
Regulation of Pleiotrophin and Fyn in the striatum of rats undergoing L-DOPA-induced dyskinesia
Keywords: L-DOPA; 6-OHDA; 6-hydroxydopamine; AIMs; abnormal involuntary movements; DA; dopamine; L-DOPA; L-3,4-dihidroxiphenyl-alanine; LID; L-DOPA induced dyskinesia; MSNs; medium spiny neurons; NMDA; N-methyl-d-aspartate; NMDAR; NMDA receptor; PD; Parkinson's Disease;
Radioguided hepatic resection with l-DOPA in metastatic medullary thyroid carcinoma
Keywords: L-DOPA; Medullary thyroid carcinoma; l-Dopa Medullary; Radioguided surgery; Metastasectomy; Carcinoma medular de tiroides; l-Dopa; CirugÃa radioguiada; MetastasectomÃa;
L-3,4-Dihydroxyphenylalanine (l-DOPA) induces neuroendocrinological, physiological, and immunological regulation in white shrimp, Litopenaeus vannamei
Keywords: L-DOPA; Litopenaeus vannamei; Vibrio alginolyticus; l-DOPA; Immune responses; Stress responses;
Selegiline increases on time without exacerbation of dyskinesia in 6-hydroxydopamine-lesioned rats displaying l-Dopa-induced wearing-off and abnormal involuntary movements
Keywords: L-DOPA; 6-OHDA; 6-hydroxydopamine; AIMs; abnormal involuntary movements; ALO; axial, forelimb and orolingual; ANOVA; analysis of variance; Arc; activity-regulated cytoskeleton-associated protein; CDS; continuous dopaminergic stimulation; COMT; catechol-O-methyltr
Helix aspersa maxima mucus exhibits antimelanogenic and antitumoral effects against melanoma cells
Keywords: L-DOPA; BCA; bicinchoninic acid; BSA; bovine serum albumin; DMEM; Dulbecco's modified Eagle's medium; ECM; extracellular matrix; FBS; fetal bovine serum; Fg; fibrinogen; Fn; fibronectin; IBMX; 3-isobutyl-1-methylxanthine; L-DOPA; L-3,4-dihydroxyphenylalanine;
GDNF family receptor α-1 in the catfish: Possible implication to brain dopaminergic activity
Keywords: L-DOPA; aa; amino acid; CA; catecholamines; cfGnRH; catfish gonadotropin regulating hormone; cyp19a1; aromatase; Cont; control; DA-ergic; dopaminergic; DIG; digoxigenin; Dph; days post hatch; E2; estradiol-17β; ER; E2 receptor; F; female; GDNF; Glial cell line-d
Linagliptin potentiates the effect of l-dopa on the behavioural, biochemical and immunohistochemical changes in experimentally-induced Parkinsonism: Role of toll-like receptor 4, TGF-β1, NF-κB and glucagon-like peptide 1
Keywords: L-DOPA; Linagliptin; l-dopa; Carbidopa; Parkinsonism; Behavioural changes; Mice;
Striatal norepinephrine efflux in l-DOPA-induced dyskinesia
Keywords: L-DOPA; Parkinson's disease; l-DOPA; Dyskinesia; Norepinephrine; Striatum; Anti- DBH saporin;
Accumulation of l-DOPA in various organs of faba bean and influence of drought, nitrogen stress, and processing methods on l-DOPA yield
Keywords: L-DOPA; Drought stress; Faba bean; l-DOPA; Processing methods; Supplement N;
A novel p.L216I mutation in the glucocerebrosidase gene is associated with Parkinson's disease in Han Chinese patients
Keywords: L-DOPA; PD; Parkinson's disease; GBA; glucocerebrosidase gene; PolyPhen-2; polymorphism phenotyping v2; dbSNP 142; single nucleotide polymorphism database 142; ExAC; Exome Aggregation Consortium database; L-DOPA; L-3,4-dihydroxyphenylalanine; SIFT; Sorting Into
Cu@Fe3O4-TiO2-L-dopa: A novel and magnetic catalyst for the Chan-Lam cross-coupling reaction in ligand free conditions
Keywords: L-DOPA; Magnetic nanoparticles; TiO2 nanoparticles; Agglomeration; Leaching; L-dopa; Chan-Lam cross-coupling reaction;
Mucuna pruriens (L.) DC chemo sensitize human breast cancer cells via downregulation of prolactin-mediated JAK2/STAT5A signaling
Keywords: L-DOPA; ANOVA; Analysis of variance; PRL; prolactin; PRLR; prolactin receptor; JAK2; janus kinase 2; STAT5A; signal transducer and activator of transcription 5A; LD; levodopa; MP; Mucuna pruriens (L.) DC; MTT; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
PCB95 and PCB153 change dopamine levels and turn-over in PC12 cells
Keywords: L-DOPA; PCB; polychlorinated biphenyl; PCB153; 2,2â²,4,4â²,5,5â²-Hexachlorobiphenyl; PCB95; 2,2â²,3,5â²,6-pentachlorobiphenyl; PC12; rat pheochromocytoma cell line; DOPAL; 3,4-Dihydroxyphenylacetaldehyde; DOPAC; 3,4-Dihydroxyphenylacetic acid; L-DOPA; L-3,4-
Filgrastim (G-CSF) ameliorates Parkinsonism l-dopa therapy's drawbacks in mice
Keywords: L-DOPA; Parkinsonism; Filgrastim; l-dopa; Antioxidant; TNF-α; Caspase-3;
From Parkinson's chemotropic agent l-dopa to thermally resistive carbonaceous nanocomposite of a new catechol-grafted poly(amide-imide)
Keywords: L-DOPA; l-Dopa; Catechol containing polymer; Nanocomposite; Thermal stability; Chiral poly(amide-imide);
Identification of metabolite biomarkers for L-DOPA-induced dyskinesia in a rat model of Parkinson's disease by metabolomic technology
Keywords: L-DOPA; L-DOPA; Dyskinesia; Parkinson's disease; Metabolomics; Striatum;
cJun N-terminal kinase (JNK) mediates cortico-striatal signaling in a model of Parkinson's disease
Keywords: L-DOPA; Dopamine; Striatum; Mouse; Long-term depression; Parkinson's disease; L-DOPA;
Novel approach to identify phenoloxidases inhibitors: Optimization of spectrophotometric MBTH assay for high throughput use enzymatic assays and analysis
Keywords: L-DOPA; High throughput screening assay development; 3-Methyl-2-benzothiazolinone hydrazone hydrochloride; Spectrophotometric; Phenoloxidase inhibition; Post-mortem melanosis; Penaeus monodon.; POs; polyphenol oxidase type enzymes; MBTH; 3-methyl-2-benzothiazolin